In terrestrial vertebrates, bone tissue constitutes the 'osteoimmune'system, which functions
as a locomotor organ and a mineral reservoir as well as a primary lymphoid organ where …

Context Antiresorptive therapy significantly reduces fracture risk in patients with benign bone
disease and skeletal-related events (SREs) in patients with bone metastases (BM) …

Medication-related osteonecrosis of the jaw (MRONJ) has become a well-known side effect
of antiresorptive, and antiangiogenic drugs commonly used in cancer management. Despite …

Tooth extraction has been avoided since it has been considered a major risk factor for
medication-related osteonecrosis of the jaw (MRONJ). However, MRONJ may also develop …

Objectives Antiresorptive medication has been reported to be associated with medication‐
related osteonecrosis of the jaw (MRONJ). This systematic review aims at investigating the …

Medication-related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse drug
effect. There are multiple hypotheses to explain the development of MRONJ. Reduced bone …

Root amputation, immunosuppressive therapy, mandibular tooth extraction, pre-existing
inflammation, and longer duration of treatment with bone-modifying agents were significantly …

Objective We reported the alveolar bone histology prior to dental extractions in cancer
patients, who received bone‐targeting agents (BTA). Subjects and Methods Fifty‐four …

Pre-existing inflammation, corticosteroid therapy, periapical periodontitis, longer duration of
denosumab therapy, and female sex were significantly associated with an increased risk of …

Objectives To compare success rates between the sub‐periosteal prepared (SPP) muco‐
periosteal flap and the epi‐periosteal prepared (EPP) mucosa flap and the feasibility of …